Latest Articles
- Renal risk stratification with the new oral anticoagulants (July 2013)
Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).
- Paget disease of bone (July 2013)
An error appeared in Paget disease of bone: Diagnosis and drug therapy. Cleve Clin J Med 2013; 80:452–462.
- Dyspnea after treatment of recurrent urinary tract infection
Glucose-6 phosphate dehydrogenase deficiency is an X-linked disorder that can present as hemolytic anemia after infection or exposure to certain medications.
- Canagliflozin: Improving diabetes by making urine sweet
Canagliflozin is the first of a new class of diabetes drugs that lower glucose by increasing its urinary excretion. An overview of its mechanism, uses, risks, and benefits.
- In Reply: Not all joint pain is arthritis (May 2013)
Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).
- A 66-year-old woman with an enlarged tongue
Eventually, she was diagnosed with multiple myeloma and cardiac amyloidosis.
- When people with diabetes go to surgery
A key take-home point is that severely insulinopenic patients require some exogenous basal insulin, even when not eating.
- Sleep disturbances in cancer patients: Underrecognized and undertreated
In cancer patients, sleep disturbances are a treatable problem that profoundly affect all aspects of quality of life.
- In Reply: Renal risk stratification with the new oral anticoagulants (July 2013)
Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).
- Not all joint pain is arthritis (May 2013)
Readers comment on the risk of bleeding with the new oral anticoagulants (July 2013) and on the signs of rheumatoid arthritis (May 2013).